巴西的有效率数据的分类:
https://www.toutiao.com/a6917212628884587019/?
那为何巴西的有效率数据最低?与巴西的统计方法有关。据相关媒体报道,在巴西的临床试验中,感染者都被分成了6类:无症状者、非常轻微症状者、轻微症状者、1级中度症状者,2级中度症状者,严重症状者。
具体来看,50.38%的有效率,只包含后面的5类症状;包含后4类症状,有效率便可达78%;若只比较严重症状者,则有效率可达100%。
Pfizer等的protocol是症状结合PCR test:
https://www.bmj.com/content/bmj/371/bmj.m4058.full.pdf
但是Peter Doshi提出质疑。需要更多细节和原始数据:
“Suspected covid-19”
All attention has focused on the dramatic efficacy results: Pfizer reported 170 PCR confirmed covid-19 cases, split 8 to 162 between vaccine and placebo groups. But these numbers were dwarfed by a category of disease called “suspected covid-19”—those with symptomatic covid-19 that were not PCR confirmed. According to FDA’s report on Pfizer’s vaccine, there were “3410 total cases of suspected, but unconfirmed covid-19 in the overall study population, 1594 occurred in the vaccine group vs. 1816 in the placebo group.”
打疫苗的有疑似症状的远多于没有打疫苗的。Doshi质疑的要点是PCR测试假阴性。所以要求更多细节和原始数据。在没有这些数据之前,总体的实际效果似乎和Pfizer差不多。